Larimar Therapeutics
LRMR
#8003
Rank
โ‚น38.27 B
Marketcap
โ‚น368.46
Share price
-3.45%
Change (1 day)
12.64%
Change (1 year)

Larimar Therapeutics (LRMR) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚น4.80 Billion

According to Larimar Therapeutics's latest financial reports the company's total liabilities are โ‚น4.80 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Larimar Therapeutics - Total liabilities on balance sheet (from 2019 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น6.08 B149.54%
2024-12-31โ‚น2.43 B105.97%
2023-12-31โ‚น1.18 B-7.75%
2022-12-31โ‚น1.28 B20.91%
2021-12-31โ‚น1.06 B-3.25%
2020-12-31โ‚น1.09 B160.85%
2019-12-31โ‚น0.42 B